TY - JOUR AU - Barre-Sinoussi, F. AU - Chermann, J. C. AU - Rey, F. AU - Nugeyre, M. T. AU - Chamaret, S. AU - Gruest, J. AU - Dauguet, C. PY - 1983 DA - 1983// TI - Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) JO - Science VL - 220 UR - https://doi.org/10.1126/science.6189183 DO - 10.1126/science.6189183 ID - Barre-Sinoussi1983 ER - TY - JOUR AU - Khowsroy, K. AU - Dhitavat, J. AU - Sabmee, Y. AU - Laowarakul, P. AU - Wattanakitwichai, J. AU - Auetian, J. PY - 2014 DA - 2014// TI - Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding JO - AIDS Res Hum Retrovir. VL - 30 UR - https://doi.org/10.1089/aid.2013.0136 DO - 10.1089/aid.2013.0136 ID - Khowsroy2014 ER - TY - JOUR AU - Plotkin, S. A. PY - 2010 DA - 2010// TI - The RV144 Thai HIV vaccine trial JO - Hum Vaccines VL - 6 ID - Plotkin2010 ER - TY - JOUR AU - Rerks-Ngarm, S. AU - Pitisuttithum, P. AU - Nitayaphan, S. AU - Kaewkungwal, J. AU - Chiu, J. AU - Paris, R. PY - 2009 DA - 2009// TI - Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0908492 DO - 10.1056/NEJMoa0908492 ID - Rerks-Ngarm2009 ER - TY - JOUR AU - Robb, M. L. AU - Rerks-Ngarm, S. AU - Nitayaphan, S. AU - Pitisuttithum, P. AU - Kaewkungwal, J. AU - Kunasol, P. PY - 2012 DA - 2012// TI - Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post hoc analysis of the Thai phase 3 efficacy trial RV 144 JO - Lancet Infect Dis. VL - 12 UR - https://doi.org/10.1016/S1473-3099(12)70088-9 DO - 10.1016/S1473-3099(12)70088-9 ID - Robb2012 ER - TY - JOUR AU - Vaccari, M. AU - Poonam, P. AU - Franchini, G. PY - 2010 DA - 2010// TI - Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV JO - Expert Rev Vaccines VL - 9 UR - https://doi.org/10.1586/erv.10.104 DO - 10.1586/erv.10.104 ID - Vaccari2010 ER - TY - JOUR AU - Hammer, S. M. AU - Sobieszczyk, M. E. AU - Janes, H. AU - Karuna, S. T. AU - Mulligan, M. J. AU - Grove, D. AU - Koblin, B. A. PY - 2013 DA - 2013// TI - Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310566 DO - 10.1056/NEJMoa1310566 ID - Hammer2013 ER - TY - JOUR AU - Bright, R. A. AU - Carter, D. M. AU - Daniluk, S. AU - Toapanta, F. R. AU - Ahmad, A. AU - Gavrilov, V. PY - 2007 DA - 2007// TI - Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.01.106 DO - 10.1016/j.vaccine.2007.01.106 ID - Bright2007 ER - TY - JOUR AU - Culbertson, C. G. AU - Peck, F. B. AU - Powell, H. M. PY - 1956 DA - 1956// TI - Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL) JO - J Am Med Assoc VL - 162 UR - https://doi.org/10.1001/jama.1956.02970320021006 DO - 10.1001/jama.1956.02970320021006 ID - Culbertson1956 ER - TY - JOUR AU - Hilleman, M. R. PY - 1993 DA - 1993// TI - Hepatitis and hepatitis A vaccine: a glimpse of history JO - J Hepatol VL - 18 UR - https://doi.org/10.1016/S0168-8278(05)80370-8 DO - 10.1016/S0168-8278(05)80370-8 ID - Hilleman1993 ER - TY - JOUR AU - Lifson, J. D. AU - Rossio, J. L. AU - Piatak, M. AU - Bess, J. AU - Chertova, E. AU - Schneider, D. K. PY - 2004 DA - 2004// TI - Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins JO - AIDS Res Hum Retrovir. VL - 20 UR - https://doi.org/10.1089/0889222041524661 DO - 10.1089/0889222041524661 ID - Lifson2004 ER - TY - JOUR AU - Miller, N. Z. PY - 2004 DA - 2004// TI - The polio vaccine; a critical assessment of its arcane history, efficacy, and long-term health-related consequences JO - Med Veritas VL - 2 UR - https://doi.org/10.1588/medver.2004.01.00027 DO - 10.1588/medver.2004.01.00027 ID - Miller2004 ER - TY - JOUR AU - Murphey-Corb, M. AU - Martin, L. N. AU - Davison-Fairburn, B. AU - Montelaro, R. C. AU - Miller, M. AU - West, M. PY - 1989 DA - 1989// TI - A formalin-inactivated whole SIV vaccine confers protection in macaques JO - Science VL - 246 UR - https://doi.org/10.1126/science.2555923 DO - 10.1126/science.2555923 ID - Murphey-Corb1989 ER - TY - STD TI - Orchestra Therapeutics discontinues its HIV vaccine development program. 2007. http://www.biospace.com/News/orchestra-therapeutics-discontinues-its-hiv/63327. UR - http://www.biospace.com/News/orchestra-therapeutics-discontinues-its-hiv/63327 ID - ref14 ER - TY - JOUR AU - Rossio, J. L. AU - Esser, M. T. AU - Suryanarayana, K. AU - Schneider, D. K. AU - Bess, J. W. AU - Vasquez, G. M. PY - 1998 DA - 1998// TI - Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins JO - J Virol VL - 72 ID - Rossio1998 ER - TY - JOUR AU - Race, E. AU - Frezza, P. AU - Stephens, D. M. AU - Davis, D. AU - Polyanskaya, N. AU - Cranage, M. PY - 1995 DA - 1995// TI - An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses JO - Vaccine VL - 13 UR - https://doi.org/10.1016/0264-410X(95)80011-2 DO - 10.1016/0264-410X(95)80011-2 ID - Race1995 ER - TY - JOUR AU - Poon, B. AU - Safrit, J. T. AU - McClure, H. AU - Kitchen, C. AU - Hsu, J. F. AU - Gudeman, V. PY - 2005 DA - 2005// TI - Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1 JO - J Virol VL - 79 UR - https://doi.org/10.1128/JVI.79.8.4927-4935.2005 DO - 10.1128/JVI.79.8.4927-4935.2005 ID - Poon2005 ER - TY - JOUR AU - Rios, A. AU - Quesada, J. AU - Anderson, D. AU - Goldstein, A. AU - Fossum, T. AU - Colby-Germinario, S. PY - 2011 DA - 2011// TI - Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors JO - Virus Res VL - 155 UR - https://doi.org/10.1016/j.virusres.2010.10.004 DO - 10.1016/j.virusres.2010.10.004 ID - Rios2011 ER - TY - BOOK PY - 2008 DA - 2008// TI - A challenge to the field, a roadmap for progress PB - International AIDS Vaccine Initiative-IAVI CY - New York ID - ref19 ER - TY - JOUR AU - Mascola, J. R. PY - 2015 DA - 2015// TI - The modern era of HIV-1 vaccine development JO - Science VL - 349 UR - https://doi.org/10.1126/science.aac7800 DO - 10.1126/science.aac7800 ID - Mascola2015 ER - TY - JOUR AU - Rios, A. AU - Poteet, E. C. AU - Siwak, E. B. AU - Anderson, D. W. AU - Yao, Q. C. PY - 2015 DA - 2015// TI - HIV inactivation: time for a second look JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000522 DO - 10.1097/QAD.0000000000000522 ID - Rios2015 ER - TY - JOUR AU - Sheppard, H. W. AU - Dorman, B. P. PY - 2015 DA - 2015// TI - Time for a systematic look at inactivated HIV vaccines JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000476 DO - 10.1097/QAD.0000000000000476 ID - Sheppard2015 ER - TY - STD TI - Flint SJ, Enquist LW, Racaniello VR, Skalka AM. Human immunodeficiency virus pathogenesis. In Principles of virology. Volume II. Edited by Press A; 2009. p 172. ID - ref23 ER - TY - JOUR AU - Li, Y. AU - Luo, L. AU - Thomas, D. Y. AU - Kang, C. Y. PY - 1994 DA - 1994// TI - Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences JO - Virology VL - 204 UR - https://doi.org/10.1006/viro.1994.1531 DO - 10.1006/viro.1994.1531 ID - Li1994 ER - TY - JOUR AU - Ascarateil, S. AU - Dupuis, L. PY - 2006 DA - 2006// TI - Surfactants in vaccine adjuvants: description and perspectives JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2005.01.134 DO - 10.1016/j.vaccine.2005.01.134 ID - Ascarateil2006 ER - TY - JOUR AU - Gao, Y. AU - Paxinos, E. AU - Galovich, J. AU - Troyer, R. AU - Baird, H. AU - Abreha, M. PY - 2004 DA - 2004// TI - Characterization of a subtype D human immunodeficiency virus type 1 isolate that was obtained from an untreated individual and that is highly resistant to nonnucleoside reverse transcriptase inhibitors JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.10.5390-5401.2004 DO - 10.1128/JVI.78.10.5390-5401.2004 ID - Gao2004 ER - TY - JOUR AU - Ding, S. AU - Veillette, M. AU - Coutu, M. AU - Prevost, J. AU - Scharf, L. AU - Bjorkman, P. J. PY - 2016 DA - 2016// TI - A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies JO - J Virol VL - 90 UR - https://doi.org/10.1128/JVI.02779-15 DO - 10.1128/JVI.02779-15 ID - Ding2016 ER - TY - JOUR AU - Veillette, M. AU - Coutu, M. AU - Richard, J. AU - Batraville, L. A. AU - Dagher, O. AU - Bernard, N. PY - 2015 DA - 2015// TI - The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals JO - J Virol VL - 89 UR - https://doi.org/10.1128/JVI.02868-14 DO - 10.1128/JVI.02868-14 ID - Veillette2015 ER - TY - STD TI - Protocol for neutralizing antibody screening assay for HIV-1 in TZM-bl cells. 2010. http://www.hiv.lanl.gov/content/nab-reference-strains/html/home.htm. UR - http://www.hiv.lanl.gov/content/nab-reference-strains/html/home.htm ID - ref29 ER - TY - JOUR AU - Montefiori, D. C. AU - Hill, T. S. AU - Vo, H. T. AU - Walker, B. D. AU - Rosenberg, E. S. PY - 2001 DA - 2001// TI - Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection JO - J Virol VL - 75 UR - https://doi.org/10.1128/JVI.75.21.10200-10207.2001 DO - 10.1128/JVI.75.21.10200-10207.2001 ID - Montefiori2001 ER - TY - JOUR AU - Keele, B. F. AU - Giorgi, E. E. AU - Salazar-Gonzalez, J. F. AU - Decker, J. M. AU - Pham, K. T. AU - Salazar, M. G. PY - 2008 DA - 2008// TI - Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0802203105 DO - 10.1073/pnas.0802203105 ID - Keele2008 ER - TY - JOUR AU - Gabuzda, D. H. AU - Lawrence, K. AU - Langhoff, E. AU - Terwilliger, E. AU - Dorfman, T. AU - Haseltine, W. A. PY - 1992 DA - 1992// TI - Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes JO - J Virol VL - 66 ID - Gabuzda1992 ER - TY - JOUR AU - Long, E. M. AU - Rainwater, S. M. AU - Lavreys, L. AU - Mandaliya, K. AU - Overbaugh, J. PY - 2002 DA - 2002// TI - HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus JO - AIDS Res Hum Retrovir. VL - 18 UR - https://doi.org/10.1089/088922202753747914 DO - 10.1089/088922202753747914 ID - Long2002 ER - TY - JOUR AU - Dugast, A. S. AU - Stamatatos, L. AU - Tonelli, A. AU - Suscovich, T. J. AU - Licht, A. F. AU - Mikell, I. PY - 2014 DA - 2014// TI - Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection JO - Eur J Immunol VL - 44 UR - https://doi.org/10.1002/eji.201344305 DO - 10.1002/eji.201344305 ID - Dugast2014 ER - TY - JOUR AU - Carrillo, J. AU - Molinos-Albert, L. M. AU - Rodriguez de la Concepcion, M. L. AU - Marfil, S. AU - Garcia, E. AU - Derking, R. PY - 2015 DA - 2015// TI - Gp120/CD4 blocking antibodies are frequently elicited in ART-naive chronically HIV-1 infected individuals JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0120648 DO - 10.1371/journal.pone.0120648 ID - Carrillo2015 ER - TY - JOUR AU - Veillette, M. AU - Desormeaux, A. AU - Medjahed, H. AU - Gharsallah, N. E. AU - Coutu, M. AU - Baalwa, J. AU - Guan, Y. AU - Lewis, G. AU - Ferrari, G. AU - Hahn, B. H. PY - 2014 DA - 2014// TI - Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity JO - J Virol VL - 88 UR - https://doi.org/10.1128/JVI.03230-13 DO - 10.1128/JVI.03230-13 ID - Veillette2014 ER - TY - JOUR AU - Fiebig, E. W. AU - Wright, D. J. AU - Rawal, B. D. AU - Garrett, P. E. AU - Schumacher, R. T. AU - Peddada, L. PY - 2003 DA - 2003// TI - Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection JO - AIDS VL - 17 UR - https://doi.org/10.1097/00002030-200309050-00005 DO - 10.1097/00002030-200309050-00005 ID - Fiebig2003 ER - TY - JOUR AU - Wu, X. AU - Yang, Z. Y. AU - Li, Y. AU - Hogerkorp, C. M. AU - Schief, W. R. AU - Seaman, M. S. PY - 2010 DA - 2010// TI - Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 JO - Science VL - 329 UR - https://doi.org/10.1126/science.1187659 DO - 10.1126/science.1187659 ID - Wu2010 ER - TY - JOUR AU - Zhou, T. AU - Georgiev, I. AU - Wu, X. AU - Yang, Z. Y. AU - Dai, K. AU - Finzi, A. PY - 2010 DA - 2010// TI - Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 JO - Science VL - 329 UR - https://doi.org/10.1126/science.1192819 DO - 10.1126/science.1192819 ID - Zhou2010 ER - TY - JOUR AU - Jardine, J. G. AU - Ota, T. AU - Sok, D. AU - Pauthner, M. AU - Kulp, D. W. AU - Kalyuzhniy, O. PY - 2015 DA - 2015// TI - HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen JO - Science VL - 349 UR - https://doi.org/10.1126/science.aac5894 DO - 10.1126/science.aac5894 ID - Jardine2015 ER - TY - JOUR AU - Sanders, R. W. AU - Gils, M. J. AU - Derking, R. AU - Sok, D. AU - Ketas, T. J. AU - Burger, J. A. PY - 2015 DA - 2015// TI - HIV-1 VACCINES: HIV-1 neutralizing antibodies induced by native-like envelope trimers JO - Science VL - 349 UR - https://doi.org/10.1126/science.aac4223 DO - 10.1126/science.aac4223 ID - Sanders2015 ER - TY - JOUR AU - Altfeld, M. AU - Allen, T. M. AU - Yu, X. G. AU - Johnston, M. N. AU - Agrawal, D. AU - Korber, B. T. PY - 2002 DA - 2002// TI - HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus JO - Nature VL - 420 UR - https://doi.org/10.1038/nature01200 DO - 10.1038/nature01200 ID - Altfeld2002 ER - TY - JOUR AU - Grobler, J. AU - Gray, C. M. AU - Rademeyer, C. AU - Seoighe, C. AU - Ramjee, G. AU - Karim, S. A. PY - 2004 DA - 2004// TI - Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers JO - J Infect Dis VL - 190 UR - https://doi.org/10.1086/423940 DO - 10.1086/423940 ID - Grobler2004 ER - TY - JOUR AU - Jost, S. AU - Bernard, M. C. AU - Kaiser, L. AU - Yerly, S. AU - Hirschel, B. AU - Samri, A. PY - 2002 DA - 2002// TI - A patient with HIV-1 superinfection JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020263 DO - 10.1056/NEJMoa020263 ID - Jost2002 ER - TY - JOUR AU - Redd, A. D. AU - Quinn, T. C. AU - Tobian, A. A. PY - 2013 DA - 2013// TI - Frequency and implications of HIV superinfection JO - Lancet Infect Dis. VL - 13 UR - https://doi.org/10.1016/S1473-3099(13)70066-5 DO - 10.1016/S1473-3099(13)70066-5 ID - Redd2013 ER -